ArticleCureus2024
Childhood Idiopathic Epilepsy in Saudi Arabia From 1990-2019: Analysis of the Global Burden of Disease Data, 2019.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction In Saudi Arabia, the epidemiological estimates of childhood epilepsy are lacking. However, only a handful of studies have been performed to explore the epidemiology of childhood epilepsy. The objective of this study was to identify the burden of childhood idiopathic epilepsy in Saudi Arabia from 1990 to 2019 using Global Burden of Disease (GBD) 2019 study data. Methods Data on the burden of childhood idiopathic epilepsy (children aged 0-14 years) in Saudi Arabia from the GBD 2019 study was reviewed and presented. The outcome measures of the study were incidence, prevalence, deaths, years of life lost (YLLs), years lived with disability (YLDs), and disability-adjusted life-years (DALYs) of childhood idiopathic epilepsy. Results In Saudi Arabia, the incident counts, prevalence, deaths, YLLs, YLDs, and DALYs were 5,365, 26,275, 58, 4,808, 9,466, and 14,273, respectively in 1990. The incidence [25.32% (95% uncertainty interval (UI): -64.00 to 379.03)], prevalence [35.40% (95% UI: -61.37 to 419.98)], and YLDs [7.99% (95% UI: -74.80 to 371.75)] rate (per 100,000 population) increased between 1990 and 2019. On the other hand, the death [-69.21% (95% UI: -82.54 to -34.86)], YLLs [-69.97% (95% UI: -83.13 to -35.81)], and DALYs [-18.27% (95% UI: -73.15 to 119.87)] rate (per 100,000 population) dropped between the same duration. Conclusion In the last three decades, the incidence and prevalence of childhood idiopathic epilepsy have modestly increased in Saudi Arabia, but the number of deaths has fallen substantially. Further research studies are needed from Saudi Arabia to understand the regional, gender-based, and socioeconomic differences of childhood idiopathic epilepsy and its impact on the psycho-cognitive development and quality of life of children.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.